Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5191718
Max Phase: Preclinical
Molecular Formula: C31H49N3O6
Molecular Weight: 559.75
Associated Items:
ID: ALA5191718
Max Phase: Preclinical
Molecular Formula: C31H49N3O6
Molecular Weight: 559.75
Associated Items:
Canonical SMILES: CC(/C=C/[C@H]1O[C@H](C)C[C@@]2(CO2)[C@@H]1O)=C\C[C@@H]1O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)NC(=O)N2CCCCC2)C[C@@H]1C
Standard InChI: InChI=1S/C31H49N3O6/c1-20(10-13-27-29(36)31(19-38-31)18-23(4)39-27)9-12-26-21(2)17-25(24(5)40-26)33-28(35)14-11-22(3)32-30(37)34-15-7-6-8-16-34/h9-11,13-14,21-27,29,36H,6-8,12,15-19H2,1-5H3,(H,32,37)(H,33,35)/b13-10+,14-11-,20-9+/t21-,22-,23+,24+,25+,26-,27+,29+,31+/m0/s1
Standard InChI Key: ZHUAXJGBLXMCFV-DUEPXHNKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 559.75 | Molecular Weight (Monoisotopic): 559.3621 | AlogP: 3.62 | #Rotatable Bonds: 8 |
Polar Surface Area: 112.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.91 | CX Basic pKa: | CX LogP: 2.45 | CX LogD: 2.45 |
Aromatic Rings: 0 | Heavy Atoms: 40 | QED Weighted: 0.24 | Np Likeness Score: 1.59 |
1. Ghosh AK, Mishevich JL, Jurica MS.. (2021) Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors., 84 (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100] |
Source(1):